文献速递精神分裂症与精神病性障碍

精神分裂症中含软骨凝集素的生长抑素神经元分子改变依回路情境而异

Molecular alterations in chondrolectin-containing somatostatin neurons in schizophrenia differ based on circuit context.
PubMed 文献 · Mol Psychiatry · 2026-08-10

该研究利用死后脑组织多重荧光原位杂交,比较精神分裂症与对照者DLPFC深层6层及邻近白质与尾状核中CHODL-SST神经元的CHODL、SST、NPY和NOS1 mRNA水平。结果显示DLPFC中四种转录本均降低(效应量-0.29至-0.52),而尾状核效应量微小且贝叶斯分析支持无差异,诊断与脑区交互作用显著(均p<0.005)。结论提示分子改变具有区域选择性,优先影响皮层群体。

要点

  • 精神分裂症中CHODL-SST神经元的分子改变在DLPFC显著而在尾状核不明显。
  • DLPFC中CHODL、SST、NPY和NOS1 mRNA水平均降低,效应量小至中等。
  • 诊断与脑区交互作用显著(均p<0.005),提示皮层与纹状体群体分离。

核心结论

  • 精神分裂症相关CHODL-SST神经元分子改变具有区域选择性,优先影响皮层群体而非纹状体群体。
  • 结果不支持均一的细胞内在脆弱性模型,而支持亚型分子特征与区域回路情境交互导致差异易感性的模型。

研究设计与样本

  • 研究采用死后脑组织多重荧光原位杂交,比较18对匹配的精神分裂症与未受影响对照个体。
  • 检测脑区为背外侧前额叶皮层深层6层及邻近皮层下白质与尾状核。
  • 在CHODL-SST神经元内定量CHODL、SST、NPY和NOS1的mRNA水平。

主要发现

  • DLPFC中CHODL-SST神经元四种转录本mRNA水平在精神分裂症中均降低,效应量-0.29至-0.52。
  • 尾状核中效应量微小(-0.13至0.03),贝叶斯分析提供强烈证据支持精神分裂症中无差异。
  • 每个转录本均显示显著的诊断与脑区交互作用(所有p<0.005),突出皮层与纹状体CHODL-SST神经元之间的显著分离。

关键数值与推荐

  • DLPFC中CHODL-SST神经元mRNA降低效应量为-0.29至-0.52(小至中等)。
  • 尾状核效应量为-0.13至0.03,贝叶斯分析支持无差异。
  • 诊断与脑区交互作用对所有转录本均显著(所有p<0.005)。

临床怎么用

  • 提示精神分裂症中SST神经元功能障碍的分子病理具有回路情境依赖性,应区分皮层与纹状体群体。
  • 支持开发针对皮层回路而非统一针对SST神经元的回路知情治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alterations in cortical somatostatin (SST)-containing GABAergic interneurons are among the most consistently replicated molecular findings in schizophrenia. Whether these alterations primarily reflect intrinsic cellular vulnerabilities, regional circuit context, or an interaction between the two remains unclear. To address this question, we examined a transcriptionally distinct SST neuron subtype that selectively expresses chondrolectin (CHODL), referred to as CHODL-SST neurons, across two brain regions with markedly different circuit organization: deep layer 6 and adjacent subcortical white matter of the dorsolateral prefrontal cortex (DLPFC) and the caudate nucleus.Using multiplex fluorescent in situ hybridization in postmortem tissue from 18 matched pairs of schizophrenia and unaffected comparison individuals, we quantified mRNA levels of CHODL, SST, neuropeptide Y (NPY), and nitric oxide synthase (NOS1) within CHODL-SST neurons in both regions.In the DLPFC, CHODL-SST neurons exhibited lower mRNA levels for all four transcripts in schizophrenia, with small-to-medium effect sizes (-0.29 to -0.52). In contrast, effect sizes in the caudate were nominal (-0.13 to 0.03), with Bayesian analyses providing strong evidence for no difference in schizophrenia. For every transcript, a significant diagnosis-by-region interaction (all p < 0.005) highlighted a striking dissociation between cortical and striatal CHODL-SST neurons.These findings indicate that schizophrenia-associated molecular alterations in CHODL-SST neurons are regionally selective and preferentially affect cortical populations. Rather than reflecting uniform cell-intrinsic vulnerability, these results support a model in which differential vulnerability emerges from the interaction between subtype-specific molecular features and regional circuit context, with implications for understanding SST neuron dysfunction and developing circuit-informed therapeutic strategies.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dienel SJ, Vespoli JC, Lewis DA, et al. Molecular alterations in chondrolectin-containing somatostatin neurons in schizophrenia differ based on circuit context. Mol Psychiatry. 2026. PMID: 42576008. doi:10.1038/s41380-026-03763-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。